These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21295812)

  • 1. Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.
    Liu SH; Smyth-Templeton N; Davis AR; Davis EA; Ballian N; Li M; Liu H; Fisher W; Brunicardi FC
    Surgery; 2011 Apr; 149(4):484-95. PubMed ID: 21295812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal insulin promoter-thymidine kinase gene therapy followed by ganciclovir effectively ablates human pancreatic cancer in mice.
    Wu JX; Liu SH; Nemunaitis JJ; Brunicardi FC
    Cancer Lett; 2015 Apr; 359(2):206-10. PubMed ID: 25596375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK/GCV gene therapy.
    Liu SH; Davis A; Li Z; Ballian N; Davis E; Wang XP; Fisher W; Brunicardi FC
    J Surg Res; 2007 Jul; 141(1):45-52. PubMed ID: 17512546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous delivery of liposome-mediated nonviral DNA is less toxic than intraperitoneal delivery in mice.
    Wang XP; Yazawa K; Templeton NS; Yang J; Liu S; Li Z; Li M; Yao Q; Chen C; Brunicardi FC
    World J Surg; 2005 Mar; 29(3):339-43. PubMed ID: 15706434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.
    Tirone TA; Wang XP; Templeton NS; Lee T; Nguyen L; Fisher W; Brunicardi FC
    World J Surg; 2004 Aug; 28(8):826-33. PubMed ID: 15457366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel synthetic human insulin super promoter for targeting PDX-1-expressing pancreatic cancer.
    Liu SH; Yu J; Sanchez R; Liu X; Heidt D; Willey J; Nemunaitis J; Brunicardi FC
    Cancer Lett; 2018 Apr; 418():75-83. PubMed ID: 29309817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
    Wang ZX; Bian HB; Yang JS; De W; Ji XH
    Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
    Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
    World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
    Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.
    Rosenfeld ME; Vickers SM; Raben D; Wang M; Sampson L; Feng M; Jaffee E; Curiel DT
    Ann Surg; 1997 May; 225(5):609-18; discussion 618-20. PubMed ID: 9193188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
    Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
    Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
    Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
    Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.
    Yang L; Hwang R; Pandit L; Gordon EM; Anderson WF; Parekh D
    Ann Surg; 1996 Sep; 224(3):405-14; discussion 414-7. PubMed ID: 8813269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK.
    Hodish I; Tal R; Shaish A; Varda-Bloom N; Greenberger S; Rauchwerger A; Breitbart E; Bangio L; Ben-Shushan D; Pfeffer R; Feder B; Waitsman A; Barshack I; Goldberg I; Mazaki-Tovi S; Peled M; Harats D
    Cancer Biol Ther; 2009 Mar; 8(5):424-32. PubMed ID: 19276657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
    Zhang R; Straus FH; DeGroot LJ
    Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.